EBACW (European Biotech Acquisition) Net Income From Continuing Operations: $0.34 Mil (TTM As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EBACW European Biotech Acquisition Corp EBACW
22 GF Score
Price $0.52
View Full Analysis

What is European Biotech Acquisition Net Income From Continuing Operations?

European Biotech Acquisition EBACW 22 Net Income From Continuing Operations is $0.34 Mil as of Dec. 2022. GuruFocus rates EBACW with a GF Score™ of 22/100.

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. European Biotech Acquisition's net income from continuing operations for the three months ended in Dec. 2022 was $-0.97 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2022 was $0.34 Mil.

European Biotech Acquisition Net Income From Continuing Operations Historical Data

* Premium members only.

The historical data trend for European Biotech Acquisition's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Biotech Acquisition Net Income From Continuing Operations Chart

European Biotech Acquisition Annual Data
Trend Dec21 Dec22
Net Income From Continuing Operations
1.48 0.34

European Biotech Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Net Income From Continuing Operations Get a 7-Day Free Trial -0.45 1.51 0.20 -0.40 -0.97
EBACW
22GF Score
European Biotech Acquisition Corp EBACW
Net Income From Continuing Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Biotech Acquisition Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income From Continuing Operations of $0.34 Mil mean?
European Biotech Acquisition (EBACW) has a Net Income From Continuing Operations of $0.34 Mil as of Dec. 2022. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for European Biotech Acquisition and its competitors.
Is European Biotech Acquisition's Net Income From Continuing Operations too high?
European Biotech Acquisition's current Net Income From Continuing Operations is $0.34 Mil. Overall, European Biotech Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does European Biotech Acquisition's Net Income From Continuing Operations compare to CNTQ and LION?
European Biotech Acquisition's Net Income From Continuing Operations of $0.34 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income From Continuing Operations for a Diversified Financial Services company?
A good Net Income From Continuing Operations depends on the Diversified Financial Services industry context. However, Net Income From Continuing Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income From Continuing Operations mean?
A high Net Income From Continuing Operations can signal that a stock is expensive relative to its fundamentals. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for European Biotech Acquisition and its competitors. European Biotech Acquisition's current Net Income From Continuing Operations is $0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Biotech Acquisition stock overvalued right now?
European Biotech Acquisition (EBACW) has a current Net Income From Continuing Operations of $0.34 Mil. The current Net Income From Continuing Operations is $0.34 Mil. European Biotech Acquisition's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income From Continuing Operations calculated?
Net Income From Continuing Operations is calculated from a company's financial statements. For European Biotech Acquisition (EBACW), the current Net Income From Continuing Operations is $0.34 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

European Biotech Acquisition Business Description

Address EPFL Innovation Park Building, Lausanne, CHE, 1015
European Biotech Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for EBACW

Net Income From Continuing Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price